Anika Announces Sale of Arthrosurface and Plan to Divest Parcus Medical

Anika Therapeutics announced the divestiture of its Arthrosurface business and the intention to divest the Parcus Medical business. The companies were acquired by Anika in 2020. The move is part of Anika’s strategic shift to focus on its core hyaluronic acid technology and Regenerative Solutions portfolio.

Primo Medical Group and two...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0